3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, David Lau et al.|The Lancet|2017Cited by 843
Type 2 diabetes prevention. Experts' Group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular PharmacotherapyMagdalena Walicka, Edward Franek, Tomasz Chomiuk et al.|Kardiologia Polska|2015Cited by 3